ClinicalTrials.Veeva

Menu
V

Vitality Clinical Trials LLC | Woodbury, NY

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BFB759
EVO756
Deuruxolitinib
clindamycin phosphate
IMG-007

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis (COMPASS 2-AD)

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Active, not recruiting
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

Enrolling
Atopic Dermatitis
Atopic Dermatitis Eczema
Drug: Placebo
Drug: IMG-007

This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to...

Enrolling
Acne Vulgaris
Drug: CABTREO is a fixed-combination product of clindamycin phosphate 1.2%/BPO 3.1%/adapalene 0.15%.

This study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair l...

Enrolling
Alopecia Areata
Drug: Placebo
Drug: Deuruxolitinib

Trial sponsors

Bausch Health logo
E
I
B
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems